Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4354 Target Snapshot

Mu-type opioid receptor · SINGLE PROTEIN · Cavia porcellus

2,376Compounds
692Assays
21Approved Drugs
2,469.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P97266. Use UniProt P97266 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P97266 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mu-type opioid receptor as ChEMBL target CHEMBL4354, mapped to UniProt P97266. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mu-type opioid receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL4354
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P97266
Mu-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mu-type opioid receptor is the right protein anchor across sources, using UniProt P97266 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMu-type opioid receptor
UniProt AccessionP97266
Component TypeProtein
Sequence Length98 aa

Mu-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mu-type opioid receptor, mapped to UniProt P97266. Sequence length is 98 aa.

Mapped IDP97266
Review nameMu-type opioid receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

21
Approved
13
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC501,291.0
KI1,051.0
EC5068.0
KD59.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2113675 11.0 Ki 0.01 Preclinical
CHEMBL52451 10.89 Ki 0.013 Preclinical
CHEMBL290429 10.72 IC50 0.019 Clinical
CHEMBL300662 10.68 Ki 0.021 Preclinical
CHEMBL50594 10.59 Ki 0.026 Preclinical
CHEMBL385759 10.57 IC50 0.027 Preclinical
CHEMBL56585 10.49 Ki 0.032 Clinical
CHEMBL23362 10.47 IC50 0.034 Preclinical
CHEMBL51838 10.41 Ki 0.039 Preclinical
CHEMBL150052 10.41 Ki 0.039 Preclinical
Distribution

pChEMBL Value Distribution

123
5.0
147
5.5
265
6.0
248
6.5
250
7.0
249
7.5
258
8.0
238
8.5
188
9.0
90
9.5
pChEMBL
Approved Drugs

Approved Drugs

NALFURAFINE
CHEMBL267495
Approved 2009
NALFURAFINE HYDROCHLORIDE
CHEMBL490665
Approved 2009
LEVORPHANOL
CHEMBL592
Approved 1991
ALFENTANIL
CHEMBL634
Approved 1986
NALTREXONE
CHEMBL19019
Approved 1984
MORPHINE
CHEMBL70
Approved 1984
BUPRENORPHINE
CHEMBL511142
Approved 1981
LOPERAMIDE
CHEMBL841
Approved 1976
NALOXONE
CHEMBL80
Approved 1971
FENTANYL CITRATE
CHEMBL688
Approved 1968
FENTANYL
CHEMBL596
Approved 1968
OXYMORPHONE
CHEMBL963
Approved 1959
MEPERIDINE
CHEMBL607
Approved 1942
Assay Landscape

Assay Landscape

692
Total Assays
1,249
Tested Compounds
3
Assay Types
Binding — 373 assays, 1,249 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 124 412 7.4
cell membrane format 99 321 7.9
single protein format 78 132 7.2
assay format 68 356 7.8
cell-based format 2 16 7.7
organism-based format 2 12 8.2
Functional — 317 assays, 581 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 205 459 7.0
assay format 83 96 7.7
cell membrane format 26 15 6.6
cell-based format 3 11 6.8
ADME — 2 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 2 8 6.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine